CRISPR Therapeutics AG (CRSP)
51.16
+2.15
(+4.39%)
USD |
NASDAQ |
Oct 27, 13:26
CRISPR Therapeutics Total Return Level : 49.01 for Oct. 26, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 26, 2026 | 49.01 |
| October 23, 2026 | 49.39 |
| October 22, 2026 | 49.99 |
| October 21, 2026 | 50.50 |
| October 20, 2026 | 49.88 |
| October 19, 2026 | 50.04 |
| October 16, 2026 | 49.25 |
| October 15, 2026 | 51.52 |
| October 14, 2026 | 50.22 |
| October 13, 2026 | 50.10 |
| October 12, 2026 | 51.55 |
| October 09, 2026 | 53.39 |
| October 08, 2026 | 50.44 |
| October 07, 2026 | 52.35 |
| October 06, 2026 | 54.00 |
| October 05, 2026 | 57.34 |
| October 02, 2026 | 55.43 |
| October 01, 2026 | 55.44 |
| September 30, 2026 | 55.32 |
| September 29, 2026 | 56.00 |
| September 28, 2026 | 54.09 |
| September 25, 2026 | 54.23 |
| September 24, 2026 | 55.70 |
| September 23, 2026 | 55.76 |
| September 22, 2026 | 59.03 |
| Date | Value |
|---|---|
| September 21, 2026 | 58.33 |
| September 18, 2026 | 56.56 |
| September 17, 2026 | 57.32 |
| September 16, 2026 | 52.21 |
| September 15, 2026 | 51.83 |
| September 14, 2026 | 52.96 |
| September 11, 2026 | 51.72 |
| September 10, 2026 | 52.26 |
| September 09, 2026 | 53.45 |
| September 08, 2026 | 54.78 |
| September 04, 2026 | 55.79 |
| September 03, 2026 | 56.49 |
| September 02, 2026 | 56.92 |
| September 01, 2026 | 56.82 |
| August 31, 2026 | 56.98 |
| August 28, 2026 | 57.72 |
| August 27, 2026 | 59.37 |
| August 26, 2026 | 59.23 |
| August 25, 2026 | 60.90 |
| August 24, 2026 | 57.08 |
| August 21, 2026 | 59.50 |
| August 20, 2026 | 58.12 |
| August 19, 2026 | 59.81 |
| August 18, 2026 | 52.97 |
| August 17, 2026 | 54.28 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Vertex Pharmaceuticals, Inc. | 517.49 |
| Basilea Pharmaceutica AG | 76.25 |
| Santhera Pharmaceuticals Holding AG | 18.30 |
| BeOne Medicines Ltd. | 370.87 |
| Intellia Therapeutics, Inc. | 11.26 |